Scott Willoughby
General Counsel at SANGAMO THERAPEUTICS, INC.
Net worth: 419 348 $ as of 2024-04-29
Scott Willoughby active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SANGAMO THERAPEUTICS, INC. | General Counsel | - | - |
| Corporate Secretary | - | - |
Career history of Scott Willoughby
Former positions of Scott Willoughby
| Companies | Position | Start | End |
|---|---|---|---|
| ACHAOGEN | General Counsel | - | - |
Training of Scott Willoughby
| University of California, Berkeley | Graduate Degree |
Statistics
International
| United States | 4 |
Operational
| General Counsel | 2 |
| Corporate Secretary | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Scott Willoughby
- Experience
